Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 7 | 2012 | 47 | 1.800 |
Why?
|
| Heart-Assist Devices | 5 | 2012 | 22 | 1.630 |
Why?
|
| Cardiac Catheterization | 6 | 2017 | 89 | 1.270 |
Why?
|
| Coronary Angiography | 10 | 2023 | 91 | 1.170 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 172 | 1.110 |
Why?
|
| Coronary Artery Disease | 4 | 2023 | 123 | 1.040 |
Why?
|
| Stents | 5 | 2010 | 76 | 1.030 |
Why?
|
| Coronary Stenosis | 4 | 2006 | 14 | 0.880 |
Why?
|
| Heart Failure | 3 | 2022 | 202 | 0.820 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2010 | 6 | 0.760 |
Why?
|
| Pulmonary Embolism | 4 | 2008 | 59 | 0.730 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 23 | 0.710 |
Why?
|
| Thrombectomy | 3 | 2008 | 27 | 0.680 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2023 | 23 | 0.640 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2023 | 27 | 0.630 |
Why?
|
| Heart Transplantation | 3 | 2010 | 38 | 0.630 |
Why?
|
| Aortic Valve | 4 | 2023 | 22 | 0.590 |
Why?
|
| Coronary Vessels | 3 | 2017 | 46 | 0.590 |
Why?
|
| Thrombosis | 2 | 2022 | 59 | 0.580 |
Why?
|
| Aneurysm, False | 2 | 2007 | 5 | 0.560 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 45 | 0.550 |
Why?
|
| Cardiology | 1 | 2016 | 73 | 0.530 |
Why?
|
| Treatment Outcome | 16 | 2023 | 3478 | 0.520 |
Why?
|
| Diastole | 4 | 2010 | 32 | 0.520 |
Why?
|
| Humans | 39 | 2023 | 29337 | 0.510 |
Why?
|
| Shock, Cardiogenic | 2 | 2012 | 10 | 0.480 |
Why?
|
| Whole Blood Coagulation Time | 2 | 2012 | 4 | 0.440 |
Why?
|
| Subclavian Artery | 2 | 2010 | 4 | 0.440 |
Why?
|
| Drug-Eluting Stents | 2 | 2022 | 11 | 0.420 |
Why?
|
| Coronary Disease | 1 | 2012 | 86 | 0.410 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 92 | 0.400 |
Why?
|
| Fibrinolytic Agents | 2 | 2011 | 56 | 0.400 |
Why?
|
| Aorta | 1 | 2011 | 26 | 0.400 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 2 | 2007 | 4 | 0.390 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 29 | 0.390 |
Why?
|
| Calcinosis | 2 | 2010 | 47 | 0.390 |
Why?
|
| Foreign-Body Migration | 2 | 2008 | 25 | 0.390 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 53 | 0.390 |
Why?
|
| Pericardium | 1 | 2010 | 20 | 0.380 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 13 | 0.380 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 3 | 0.370 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 10 | 0.370 |
Why?
|
| Angioplasty | 1 | 2010 | 5 | 0.370 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2010 | 5 | 0.370 |
Why?
|
| Balloon Occlusion | 2 | 2007 | 6 | 0.370 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 4 | 0.370 |
Why?
|
| Artifacts | 2 | 2009 | 32 | 0.370 |
Why?
|
| Hepatic Veins | 1 | 2010 | 7 | 0.370 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 180 | 0.370 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 32 | 0.370 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 12 | 0.370 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 19 | 0.360 |
Why?
|
| Heart Diseases | 1 | 2010 | 73 | 0.360 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 40 | 0.320 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 2 | 0.320 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2007 | 10 | 0.320 |
Why?
|
| Vascular Surgical Procedures | 1 | 2007 | 24 | 0.310 |
Why?
|
| Mammary Arteries | 1 | 2007 | 5 | 0.310 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2023 | 9 | 0.310 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 22 | 0.310 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 6 | 0.300 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 56 | 0.300 |
Why?
|
| Transducers, Pressure | 1 | 2006 | 4 | 0.290 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 3 | 0.290 |
Why?
|
| Male | 19 | 2021 | 15621 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2010 | 770 | 0.250 |
Why?
|
| Heart Aneurysm | 1 | 2004 | 6 | 0.240 |
Why?
|
| Female | 14 | 2021 | 16197 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2010 | 957 | 0.240 |
Why?
|
| Hypotension | 1 | 2022 | 27 | 0.220 |
Why?
|
| Aged | 11 | 2021 | 9448 | 0.220 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2012 | 11 | 0.210 |
Why?
|
| Conservative Treatment | 1 | 2021 | 13 | 0.200 |
Why?
|
| Adult | 9 | 2017 | 8601 | 0.200 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 24 | 0.200 |
Why?
|
| Middle Aged | 10 | 2011 | 9823 | 0.190 |
Why?
|
| Catheterization | 3 | 2010 | 51 | 0.180 |
Why?
|
| Hemodynamics | 2 | 2010 | 83 | 0.180 |
Why?
|
| Health Resources | 1 | 2019 | 24 | 0.180 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 30 | 0.180 |
Why?
|
| Network Meta-Analysis | 3 | 2023 | 22 | 0.170 |
Why?
|
| Constriction, Pathologic | 3 | 2010 | 26 | 0.170 |
Why?
|
| Risk Assessment | 4 | 2021 | 679 | 0.160 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3273 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2007 | 44 | 0.160 |
Why?
|
| Follow-Up Studies | 3 | 2007 | 1830 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 3 | 0.160 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 10 | 0.160 |
Why?
|
| Incidental Findings | 1 | 2017 | 16 | 0.160 |
Why?
|
| Phlebography | 3 | 2017 | 9 | 0.150 |
Why?
|
| Risk Factors | 5 | 2023 | 2443 | 0.150 |
Why?
|
| Atrial Appendage | 1 | 2017 | 45 | 0.150 |
Why?
|
| Punctures | 2 | 2010 | 10 | 0.150 |
Why?
|
| Exercise Test | 1 | 2017 | 122 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2016 | 14 | 0.140 |
Why?
|
| Radial Artery | 1 | 2016 | 10 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2022 | 75 | 0.140 |
Why?
|
| Saphenous Vein | 2 | 2007 | 9 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 4851 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2008 | 170 | 0.130 |
Why?
|
| Sinus of Valsalva | 2 | 2003 | 3 | 0.120 |
Why?
|
| Aortic Rupture | 2 | 2003 | 8 | 0.120 |
Why?
|
| Aortic Aneurysm | 2 | 2003 | 10 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2023 | 39 | 0.110 |
Why?
|
| Death | 2 | 2023 | 48 | 0.110 |
Why?
|
| Erectile Dysfunction | 1 | 2013 | 46 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 788 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 19 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 32 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 1113 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2011 | 58 | 0.090 |
Why?
|
| Peptides | 1 | 2011 | 95 | 0.090 |
Why?
|
| Echocardiography | 2 | 2008 | 172 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2010 | 8 | 0.090 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 17 | 0.090 |
Why?
|
| Prosthesis Design | 2 | 2009 | 502 | 0.090 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2010 | 74 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 364 | 0.090 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2008 | 5 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 402 | 0.080 |
Why?
|
| Vena Cava Filters | 1 | 2008 | 7 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2009 | 290 | 0.080 |
Why?
|
| Gastrectomy | 1 | 2008 | 24 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2007 | 22 | 0.080 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 9 | 0.080 |
Why?
|
| Angiography | 1 | 2007 | 38 | 0.080 |
Why?
|
| Chest Pain | 1 | 2007 | 24 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 1 | 2007 | 22 | 0.080 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2006 | 3 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2006 | 13 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 22 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2006 | 57 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2007 | 209 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 81 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 222 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2019 | 141 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 24 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2004 | 59 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 16 | 0.060 |
Why?
|
| Child | 1 | 2007 | 1346 | 0.060 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 2 | 0.060 |
Why?
|
| Neprilysin | 1 | 2022 | 9 | 0.060 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 9 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 29 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 26 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2002 | 8 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2022 | 56 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 63 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 49 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 85 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 241 | 0.050 |
Why?
|
| Health Status | 1 | 2023 | 227 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 141 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 340 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2019 | 68 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 149 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 662 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 330 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 141 | 0.040 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 10 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 317 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 495 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 389 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 1616 | 0.030 |
Why?
|
| Device Removal | 2 | 2008 | 85 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2333 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 125 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 498 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 73 | 0.020 |
Why?
|
| Computer Systems | 1 | 2006 | 5 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 324 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 553 | 0.020 |
Why?
|
| Prolapse | 1 | 2003 | 1 | 0.010 |
Why?
|
| Aortography | 1 | 2003 | 10 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 71 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2002 | 3 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2002 | 13 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2002 | 11 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 34 | 0.010 |
Why?
|